EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Understanding and countering opioid‐induced respiratory depression

Jordan T Bateman, Sandy E Saunders, Erica S Levitt

British Journal of Pharmacology · 2023-04 · 180 (7) · 813-828

DOI: 10.1111/bph.15580 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, online erschienen am 26.06.2021. Verfasst von Jordan T Bateman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Therapeutics, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Opiate Overdose, Respiratory Insufficiency. Die Arbeit wurde bisher 139-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory depression is the proximal cause of death in opioid overdose, yet the mechanisms underlying this potentially fatal outcome are not well understood. The goal of this review is to provide a comprehensive understanding of the pharmacological mechanisms of opioid‐induced respiratory depression, which could lead to improved therapeutic options to counter opioid overdose, as well as other detrimental effects of opioids on breathing. The development of tolerance in the respiratory system is also discussed, as are differences in the degree of respiratory depression caused by various opioid agonists. Finally, potential future therapeutic agents aimed at reversing or avoiding opioid‐induced respiratory depression through non‐opioid receptor targets are in development and could provide certain advantages over naloxone. By providing an overview of mechanisms and effects of opioids in the respiratory network, this review will benefit future research on countering opioid‐induced respiratory depression. LINKED ARTICLES This article is part of a themed issue on Advances in Opioid Pharmacology at the Time of the Opioid Epidemic. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v180.7/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opiate OverdoseRespiratory InsufficiencyHumansAnalgesics, OpioidNaloxoneRespiration

Stichwörter der Autor:innen

addictionbrainstemcontrol of breathingelectrophysiologymu opioid receptoropioidsrespiratory pharmacology

Substanzen

Analgesics, OpioidNaloxone

Autor:innen und Institutionen

  • Department of Pharmacology & Therapeutics, University of Florida, Gainesville, Florida, USA.
  • Breathing Research and Therapeutics Center, University of Florida, Gainesville, Florida, USA.

Förderung

  • NIDA NIH HHS
  • National Institutes of Health

Zitieren

APA

Bateman, J. T., Saunders, S. E., & Levitt, E. S. (2023). Understanding and countering opioid‐induced respiratory depression. British Journal of Pharmacology, 180(7), 813-828. https://doi.org/10.1111/bph.15580

Vancouver

Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid‐induced respiratory depression. British Journal of Pharmacology. 2023;180(7):813-828. doi:10.1111/bph.15580

BibTeX
@article{Bateman2023,
  author = {Bateman, Jordan T and Saunders, Sandy E and Levitt, Erica S},
  title = {Understanding and countering opioid‐induced respiratory depression},
  journal = {British Journal of Pharmacology},
  year = {2023},
  volume = {180},
  number = {7},
  pages = {813--828},
  doi = {10.1111/bph.15580}
}
Kostenlos starten →